Skip to main content
PMC home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1996 Mar;16(3):771–777. doi: 10.1128/mcb.16.3.771

Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia.

A S Jun 1, I A Trounce 1, M D Brown 1, J M Shoffner 1, D C Wallace 1
PMCID: PMC231057  PMID: 8622678

Abstract

A heteroplasmic G-to-A transition at nucleotide pair (np) 14459 within the mitochondrial DNA (mtDNA)-encoded NADH dehydrogenase subunit 6 (ND6) gene has been identified as the cause of Leber hereditary optic neuropathy (LHON) and/or pediatric-onset dystonia in three unrelated families. This ND6 np 14459 mutation changes a moderately conserved alanine to a valine at amino acid position 72 of the ND6 protein. Enzymologic analysis of mitochondrial NADH dehydrogenase (complex I) with submitochondrial particles isolated from Epstein-Barr virus-transformed lymphoblasts revealed a 60% reduction (P < 0.005) of complex I-specific activity in patient cell lines compared with controls, with no differences in enzymatic activity for complexes II plus III, III and IV. This biochemical defect was assigned to the ND6 np 14459 mutation by using transmitochondrial cybrids in which patient Epstein-Barr virus-transformed lymphoblast cell lines were enucleated and the cytoplasts were fused to a mtDNA-deficient (p 0) lymphoblastoid recipient cell line. Cybrids harboring the np 14459 mutation exhibited a 39% reduction (p < 0.02) in complex I-specific activity relative to wild-type cybrid lines but normal activity for the other complexes. Kinetic analysis of the np 14459 mutant complex I revealed that the Vmax of the enzyme was reduced while the Km remained the same as that of wild type. Furthermore, specific activity was inhibited by increasing concentrations of the reduced coenzyme Q analog decylubiquinol. These observations suggest that the np 14459 mutation may alter the coenzyme Q-binding site of complex I.

Full Text

The Full Text of this article is available as a PDF (219.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S., Bankier A. T., Barrell B. G., de Bruijn M. H., Coulson A. R., Drouin J., Eperon I. C., Nierlich D. P., Roe B. A., Sanger F. Sequence and organization of the human mitochondrial genome. Nature. 1981 Apr 9;290(5806):457–465. doi: 10.1038/290457a0. [DOI] [PubMed] [Google Scholar]
  2. Beal M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol. 1992 Feb;31(2):119–130. doi: 10.1002/ana.410310202. [DOI] [PubMed] [Google Scholar]
  3. Benecke R., Strümper P., Weiss H. Electron transfer complex I defect in idiopathic dystonia. Ann Neurol. 1992 Nov;32(5):683–686. doi: 10.1002/ana.410320512. [DOI] [PubMed] [Google Scholar]
  4. Berkovic S. F., Karpati G., Carpenter S., Lang A. E. Progressive dystonia with bilateral putaminal hypodensities. Arch Neurol. 1987 Nov;44(11):1184–1187. doi: 10.1001/archneur.1987.00520230064016. [DOI] [PubMed] [Google Scholar]
  5. Bindoff L. A., Birch-Machin M. A., Cartlidge N. E., Parker W. D., Jr, Turnbull D. M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci. 1991 Aug;104(2):203–208. doi: 10.1016/0022-510x(91)90311-t. [DOI] [PubMed] [Google Scholar]
  6. Bindoff L. A., Birch-Machin M., Cartlidge N. E., Parker W. D., Jr, Turnbull D. M. Mitochondrial function in Parkinson's disease. Lancet. 1989 Jul 1;2(8653):49–49. doi: 10.1016/s0140-6736(89)90291-2. [DOI] [PubMed] [Google Scholar]
  7. Blin O., Desnuelle C., Rascol O., Borg M., Peyro Saint Paul H., Azulay J. P., Billé F., Figarella D., Coulom F., Pellissier J. F. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci. 1994 Aug;125(1):95–101. doi: 10.1016/0022-510x(94)90248-8. [DOI] [PubMed] [Google Scholar]
  8. Bruyn G. W., Bots G. T., Went L. N., Klinkhamer P. J. Hereditary spastic dystonia with Leber's hereditary optic neuropathy: neuropathological findings. J Neurol Sci. 1992 Nov;113(1):55–61. doi: 10.1016/0022-510x(92)90265-m. [DOI] [PubMed] [Google Scholar]
  9. Bruyn G. W., Vielvoye G. J., Went L. N. Hereditary spastic dystonia: a new mitochondrial encephalopathy? Putaminal necrosis as a diagnostic sign. J Neurol Sci. 1991 Jun;103(2):195–202. doi: 10.1016/0022-510x(91)90164-3. [DOI] [PubMed] [Google Scholar]
  10. Chomyn A., Cleeter M. W., Ragan C. I., Riley M., Doolittle R. F., Attardi G. URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science. 1986 Oct 31;234(4776):614–618. doi: 10.1126/science.3764430. [DOI] [PubMed] [Google Scholar]
  11. Chomyn A., Lai S. T., Shakeley R., Bresolin N., Scarlato G., Attardi G. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet. 1994 Jun;54(6):966–974. [PMC free article] [PubMed] [Google Scholar]
  12. Chomyn A., Meola G., Bresolin N., Lai S. T., Scarlato G., Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol. 1991 Apr;11(4):2236–2244. doi: 10.1128/mcb.11.4.2236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fearnley I. M., Walker J. E. Conservation of sequences of subunits of mitochondrial complex I and their relationships with other proteins. Biochim Biophys Acta. 1992 Dec 7;1140(2):105–134. doi: 10.1016/0005-2728(92)90001-i. [DOI] [PubMed] [Google Scholar]
  14. Goto Y., Nonaka I., Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990 Dec 13;348(6302):651–653. doi: 10.1038/348651a0. [DOI] [PubMed] [Google Scholar]
  15. Grégoire M., Morais R., Quilliam M. A., Gravel D. On auxotrophy for pyrimidines of respiration-deficient chick embryo cells. Eur J Biochem. 1984 Jul 2;142(1):49–55. doi: 10.1111/j.1432-1033.1984.tb08249.x. [DOI] [PubMed] [Google Scholar]
  16. Hayashi J., Ohta S., Kikuchi A., Takemitsu M., Goto Y., Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10614–10618. doi: 10.1073/pnas.88.23.10614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Heinrich H., Azevedo J. E., Werner S. Characterization of the 9.5-kDa ubiquinone-binding protein of NADH:ubiquinone oxidoreductase (complex I) from Neurospora crassa. Biochemistry. 1992 Nov 24;31(46):11420–11424. doi: 10.1021/bi00161a021. [DOI] [PubMed] [Google Scholar]
  18. Heinrich H., Werner S. Identification of the ubiquinone-binding site of NADH:ubiquinone oxidoreductase (complex I) from Neurospora crassa. Biochemistry. 1992 Nov 24;31(46):11413–11419. doi: 10.1021/bi00161a020. [DOI] [PubMed] [Google Scholar]
  19. Howell N., Kubacka I., Xu M., McCullough D. A. Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet. 1991 May;48(5):935–942. [PMC free article] [PubMed] [Google Scholar]
  20. Ichiki T., Tanaka M., Nishikimi M., Suzuki H., Ozawa T., Kobayashi M., Wada Y. Deficiency of subunits of Complex I and mitochondrial encephalomyopathy. Ann Neurol. 1988 Mar;23(3):287–294. doi: 10.1002/ana.410230312. [DOI] [PubMed] [Google Scholar]
  21. Johns D. R., Heher K. L., Miller N. R., Smith K. H. Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol. 1993 Apr;111(4):495–498. doi: 10.1001/archopht.1993.01090040087038. [DOI] [PubMed] [Google Scholar]
  22. Johns D. R., Neufeld M. J., Park R. D. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1551–1557. doi: 10.1016/0006-291x(92)90479-5. [DOI] [PubMed] [Google Scholar]
  23. Jun A. S., Brown M. D., Wallace D. C. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6206–6210. doi: 10.1073/pnas.91.13.6206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. King M. P., Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science. 1989 Oct 27;246(4929):500–503. doi: 10.1126/science.2814477. [DOI] [PubMed] [Google Scholar]
  25. King M. P., Koga Y., Davidson M., Schon E. A. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol. 1992 Feb;12(2):480–490. doi: 10.1128/mcb.12.2.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  27. Larsson N. G., Andersen O., Holme E., Oldfors A., Wahlström J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol. 1991 Nov;30(5):701–708. doi: 10.1002/ana.410300511. [DOI] [PubMed] [Google Scholar]
  28. Letellier T., Heinrich R., Malgat M., Mazat J. P. The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J. 1994 Aug 15;302(Pt 1):171–174. doi: 10.1042/bj3020171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Levy J. A., Virolainen M., Defendi V. Human lymphoblastoid lines from lymph node and spleen. Cancer. 1968 Sep;22(3):517–524. doi: 10.1002/1097-0142(196809)22:3<517::aid-cncr2820220305>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  30. Mackey D., Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet. 1992 Dec;51(6):1218–1228. [PMC free article] [PubMed] [Google Scholar]
  31. Majander A., Huoponen K., Savontaus M. L., Nikoskelainen E., Wikström M. Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett. 1991 Nov 4;292(1-2):289–292. doi: 10.1016/0014-5793(91)80886-8. [DOI] [PubMed] [Google Scholar]
  32. Marsden C. D., Lang A. E., Quinn N. P., McDonald W. I., Abdallat A., Nimri S. Familial dystonia and visual failure with striatal CT lucencies. J Neurol Neurosurg Psychiatry. 1986 May;49(5):500–509. doi: 10.1136/jnnp.49.5.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., Kagawa Y. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun. 1989 Sep 29;163(3):1450–1455. doi: 10.1016/0006-291x(89)91141-8. [DOI] [PubMed] [Google Scholar]
  34. Novotny E. J., Jr, Singh G., Wallace D. C., Dorfman L. J., Louis A., Sogg R. L., Steinman L. Leber's disease and dystonia: a mitochondrial disease. Neurology. 1986 Aug;36(8):1053–1060. doi: 10.1212/wnl.36.8.1053. [DOI] [PubMed] [Google Scholar]
  35. Parker W. D., Jr, Boyson S. J., Luder A. S., Parks J. K. Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology. 1990 Aug;40(8):1231–1234. doi: 10.1212/wnl.40.8.1231. [DOI] [PubMed] [Google Scholar]
  36. Parker W. D., Jr, Boyson S. J., Parks J. K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol. 1989 Dec;26(6):719–723. doi: 10.1002/ana.410260606. [DOI] [PubMed] [Google Scholar]
  37. Parker W. D., Jr, Oley C. A., Parks J. K. A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. N Engl J Med. 1989 May 18;320(20):1331–1333. doi: 10.1056/NEJM198905183202007. [DOI] [PubMed] [Google Scholar]
  38. Pilkington S. J., Arizmendi J. M., Fearnley I. M., Runswick M. J., Skehel J. M., Walker J. E. Structural organization of complex I from bovine mitochondria. Biochem Soc Trans. 1993 Feb;21(1):26–31. doi: 10.1042/bst0210026. [DOI] [PubMed] [Google Scholar]
  39. Schapira A. H., Cooper J. M., Dexter D., Clark J. B., Jenner P., Marsden C. D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem. 1990 Mar;54(3):823–827. doi: 10.1111/j.1471-4159.1990.tb02325.x. [DOI] [PubMed] [Google Scholar]
  40. Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B., Marsden C. D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1989 Jun 3;1(8649):1269–1269. doi: 10.1016/s0140-6736(89)92366-0. [DOI] [PubMed] [Google Scholar]
  41. Schapira A. H., Cooper J. M., Morgan-Hughes J. A., Patel S. D., Cleeter M. J., Ragan C. I., Clark J. B. Molecular basis of mitochondrial myopathies: polypeptide analysis in complex-I deficiency. Lancet. 1988 Mar 5;1(8584):500–503. doi: 10.1016/s0140-6736(88)91296-2. [DOI] [PubMed] [Google Scholar]
  42. Schapira A. H., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B., Marsden C. D. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem. 1990 Dec;55(6):2142–2145. doi: 10.1111/j.1471-4159.1990.tb05809.x. [DOI] [PubMed] [Google Scholar]
  43. Schulz J. B., Beal M. F. Mitochondrial dysfunction in movement disorders. Curr Opin Neurol. 1994 Aug;7(4):333–339. doi: 10.1097/00019052-199408000-00010. [DOI] [PubMed] [Google Scholar]
  44. Shoffner J. M., Brown M. D., Stugard C., Jun A. S., Pollock S., Haas R. H., Kaufman A., Koontz D., Kim Y., Graham J. R. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol. 1995 Aug;38(2):163–169. doi: 10.1002/ana.410380207. [DOI] [PubMed] [Google Scholar]
  45. Shoffner J. M., Wallace D. C. Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr. 1994;14:535–568. doi: 10.1146/annurev.nu.14.070194.002535. [DOI] [PubMed] [Google Scholar]
  46. Shoffner J. M., Watts R. L., Juncos J. L., Torroni A., Wallace D. C. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol. 1991 Sep;30(3):332–339. doi: 10.1002/ana.410300304. [DOI] [PubMed] [Google Scholar]
  47. Smith P. R., Cooper J. M., Govan G. G., Harding A. E., Schapira A. H. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci. 1994 Mar;122(1):80–83. doi: 10.1016/0022-510x(94)90055-8. [DOI] [PubMed] [Google Scholar]
  48. Suzuki H., Ozawa T. An ubiquinone-binding protein in mitochondrial NADH-ubiquinone reductase (Complex I). Biochem Biophys Res Commun. 1986 Aug 14;138(3):1237–1242. doi: 10.1016/s0006-291x(86)80415-6. [DOI] [PubMed] [Google Scholar]
  49. Trounce I. A., Kim Y. L., Jun A. S., Wallace D. C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 1996;264:484–509. doi: 10.1016/s0076-6879(96)64044-0. [DOI] [PubMed] [Google Scholar]
  50. Trounce I., Neill S., Wallace D. C. Cytoplasmic transfer of the mtDNA nt 8993 T-->G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8334–8338. doi: 10.1073/pnas.91.18.8334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Vinogradov A. D. Kinetics, control, and mechanism of ubiquinone reduction by the mammalian respiratory chain-linked NADH-ubiquinone reductase. J Bioenerg Biomembr. 1993 Aug;25(4):367–375. doi: 10.1007/BF00762462. [DOI] [PubMed] [Google Scholar]
  52. Wallace D. C. A new manifestation of Leber's disease and a new explanation for the agency responsible for its unusual pattern of inheritance. Brain. 1970;93(1):121–132. doi: 10.1093/brain/93.1.121. [DOI] [PubMed] [Google Scholar]
  53. Wallace D. C., Bunn C. L., Eisenstadt J. M. Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells. J Cell Biol. 1975 Oct;67(1):174–188. doi: 10.1083/jcb.67.1.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wallace D. C. Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992;61:1175–1212. doi: 10.1146/annurev.bi.61.070192.005523. [DOI] [PubMed] [Google Scholar]
  55. Wallace D. C. Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr. 1994 Jun;26(3):241–250. doi: 10.1007/BF00763096. [DOI] [PubMed] [Google Scholar]
  56. Wallace D. C. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8739–8746. doi: 10.1073/pnas.91.19.8739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wallace D. C., Shoffner J. M., Trounce I., Brown M. D., Ballinger S. W., Corral-Debrinski M., Horton T., Jun A. S., Lott M. T. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta. 1995 May 24;1271(1):141–151. doi: 10.1016/0925-4439(95)00021-u. [DOI] [PubMed] [Google Scholar]
  58. Wallace D. C., Yang J. H., Ye J. H., Lott M. T., Oliver N. A., McCarthy J. Computer prediction of peptide maps: assignment of polypeptides to human and mouse mitochondrial DNA genes by analysis of two-dimensional-proteolytic digest gels. Am J Hum Genet. 1986 Apr;38(4):461–481. [PMC free article] [PubMed] [Google Scholar]
  59. Walsh P. S., Metzger D. A., Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991 Apr;10(4):506–513. [PubMed] [Google Scholar]
  60. Yoneda M., Chomyn A., Martinuzzi A., Hurko O., Attardi G. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11164–11168. doi: 10.1073/pnas.89.23.11164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Zheng X. X., Shoffner J. M., Voljavec A. S., Wallace D. C. Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochim Biophys Acta. 1990 Aug 9;1019(1):1–10. doi: 10.1016/0005-2728(90)90118-n. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES